search icon
Join IDSAJOIN IDSA >> Go to MyIDSAGO TO MYIDSA >>
  • Print
  • ShareThis
  • Text Size
  • Global Health

    IDSA prioritizes promoting sufficient U.S. investment in global infectious diseases responses and research, and in using the voices of physician scientists to inform multilateral and national global health policies. IDSA is a trusted leader in shaping and advancing international and national policies and investments in global HIV, TB, health security and antimicrobial resistance.

    What's New?

     

    World Bank, IMF must Focus on Global Health Funding and Capacity 4/20/2018
    The Infectious Diseases Society of America appreciates the attention that the World Bank and International Monetary Fund will give to critical global health issues during their spring meetings and civil society forum.
    Click here to read more. 

    House Testimony on Global Health Programs 4/20/2018
    IDSA urges for increased funding for State Department and USAID global health programs in this testimony submitted to the House Appropriations Committee.
    Click here to read more. 

    Hank Tomlinson, Ph.D. to Lead CDC’s Global HIV and TB Efforts at Critical Time 4/18/2018
    The U.S. government response to the global impacts of HIV and tuberculosis is poised at a pivotal moment, in which we can seize the opportunity to end these devastating pandemics, or watch progress erode, infections increase, and our effective treatments compromised by growing drug resistance.
    Click here to read more. 

    PEPFAR report serves as a beacon and a warning 4/12/2018
    The 2018 Annual Report to Congress released by the United States President’s
    Emergency Plan for AIDS Relief (PEPFAR) tells a story of remarkable progress and opportunity. Click here to read more. 

    Statement on World Health Day 04/20/2018
    On World Health Day, the Infectious Diseases Society of America and the
    HIV Medicine Association appreciate the global leadership of the United States
    in responding to infectious disease threats that know no boundaries.
    Click here to read more. 
    Click here for IDSA/HIVMA Global Impact: 2018 and Beyond.

    Statement on World TB Day 03/23/2018
    Commemoration of World TB Day finds us at a promising but pivotal moment. Advances in diagnostic tools, medications, and treatment regimens are offering significant improvements to detect, treat and control tuberculosis. Click here to read more. 

    Statement on World AIDS Day 2017 12/01/2017
    On World AIDS Day, while we recognize the progress made against
    HIV globally, we must measure that progress against the
    urgent needs that remain. Click here to read more. 

    Countdown: Global HIV, Responses, Results 12/1/2017
    This briefing paper from IDSA chronicles the progress made over the past
    decade in eliminating HIV/AIDS as a global public health threat, and looks
    ahead at the work that remains in achieving epidemic control. Click here to read more.

    Red Ribbon or White Flag? The Future of the US Global AIDS Response 12/01/2017
    This report from the ONE campaign details the impacts of the White House’s
    proposed budget cuts to U.S. global HIV funding and subsequent PEPFAR
    strategy on the global AIDS response. Click here to read more. 

    The Ascent Begins: Tuberculosis Research Funding Trends, 2005-2016 11/08/2017
    The latest report from the Treatment Action Group on funding trends for global
    tuberculosis research and development shows there has been increases in
    spending on TB research, but overall funding remains inadequate for achieving
    global goals to eliminate the epidemic by 2030. Click here to read more.

    Healthier World, Safer America: A U.S. Government Roadmap 
    for International Action to Prevent the Next Pandemic 10/24/2017
    The latest report from the Treatment Action Group on funding trends for global
    tuberculosis research and development shows there has been increases in
    spending on TB research, but overall funding remains inadequate
    for achieving global goals to eliminate the epidemic by 2030. 
    Click here to read more.  

    Read More About What's New in Global Health 

    IDSA Global Health Resources

    World Bank, IMF Must Focus on Global Health Funding and Capacity

    The Infectious Diseases Society of America appreciates the attention that the World Bank and International Monetary Fund will give to critical global health issues during their spring meetings and civil society forum.

    House Testimony on Global Health Programs

    IDSA urges for increased funding for State Department and USAID global health programs in this testimony submitted to the House Appropriations Committee

    Hank Tomlinson, Ph.D. to Lead CDC’s Global HIV and TB Efforts at Critical Time

    The U.S. government response to the global impacts of HIV and tuberculosis is poised at a pivotal moment, in which we can seize the opportunity to end these devastating pandemics, or watch progress erode, infections increase, and our effective treatments compromised by growing drug resistance

    PEPFAR report serves as a beacon and a warning

    The 2018 Annual Report to Congress released by the United States President’s Emergency Plan for AIDS Relief tells a story of remarkable progress and opportunity.

    IDSA/HIVMA Global Impact: 2018 and Beyond

    IDSA/HIVMA Global Impact: 2018 and Beyond
    9/4/2017

    IDSA & HIVMA Letter on NDAA

    Dear Senators McCain and Reed:
    We are writing on behalf of the Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA) to express our opposition to provisions in S. 1519, The National Defense Authorization Act for Fiscal Year 2018 that would impose severe restrictions on medical research funded through the Department of Defense (DoD) and impose onerous requirements on research grant recipients.
    8/29/2017

    IDSA Letter to new USAID Administrator

    Dear Administrator Green,
    The Infectious Diseases Society of America extends our congratulations on your confirmation as Administrator of the U.S. Agency for International Development.
    8/29/2017

    IDSA Letter to New WHO Director General

    Dear Dr. Tedros,
    The Infectious Diseases Society of America extends our congratulations on your election as Director General of the World Health Organization.
    5/11/2017

    Report on CROI 2017

    Launched in 1993 as a forum for basic scientists and clinical investigators from around the world to share and discuss laboratory science, clinical trials and evolving practice confronting HIV and its associated impacts, the Conference on Retroviruses and Opportunistic Infections has provided the setting for presentations of landmark research heralding advances against the pandemic.

    5/11/2017

    Report on 47th Union World Conference on Lung Health

    The resistance that enabled tuberculosis to resurge from a sickness considered all but conquered in the last century, to one that in this century kills more people than any other infectious disease on earth, goes beyond the mutations of the bacteria that survive initial treatment.

    4/26/2017

    Fogarty International Center

    The Fogarty International Center, founded in 1968 and part of the National Institutes of Health, connects American scientists and health-care professionals with their global health peers to support basic, clinical, and applied research along with training programs in low-and middle-income countries.
    4/26/2017

    Updated Zika White Paper 2017

    Before the 2015 arrival of Zika virus in the Western Hemisphere, a mosquito bite had never before been linked to a devastating birth defect.

    12/1/2017

    Red Ribbon or White Flag? The Future of the US Global AIDS Response

    This report from the ONE campaign details the impacts of the White House’s proposed budget cuts to U.S. global HIV funding and subsequent PEPFAR strategy on the global AIDS response. .  

    10/24/2017

    Healthier World, Safer America: A U.S. Government Roadmap for International Action to Prevent the Next Pandemic

    This report from PATH analyzes the importance of developing a robust pipeline of new drugs, diagnostics, vaccines and other technologies for diseases likely to become pandemics, and outlines recommendations for action from the U.S. government to prevent the next pandemic. 

    11/8/2017

    The Ascent Begins: Tuberculosis Research Funding Trends, 2005-2016

    The latest report from the Treatment Action Group on funding trends for global tuberculosis research and development shows there has been increases in spending on TB research, but overall funding remains inadequate for achieving global goals to eliminate the epidemic by 2030.  

| HIVMA | Contact Us

© Copyright IDSA 2018 Infectious Diseases Society of America

Full Site Mobile Site